Data as of May 21
| +0.01 / +0.32%|
The 1 analysts offering 12-month price forecasts for Enzon Pharmaceuticals Inc have a median target of 16.00, with a high estimate of 16.00 and a low estimate of 16.00. The median estimate represents a +409.55% increase from the last price of 3.14.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.